MY115157A - Method and composition for treatment of autoimmune hepatitis - Google Patents

Method and composition for treatment of autoimmune hepatitis

Info

Publication number
MY115157A
MY115157A MYPI94002830A MYPI9402830A MY115157A MY 115157 A MY115157 A MY 115157A MY PI94002830 A MYPI94002830 A MY PI94002830A MY PI9402830 A MYPI9402830 A MY PI9402830A MY 115157 A MY115157 A MY 115157A
Authority
MY
Malaysia
Prior art keywords
composition
autoimmune hepatitis
treatment
amount
immunodulatory
Prior art date
Application number
MYPI94002830A
Other languages
English (en)
Inventor
Paul B Chretien
Milton G Mutchnick
Original Assignee
Sciclone Pharmaceuticals Inc
Univ Wayne State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sciclone Pharmaceuticals Inc, Univ Wayne State filed Critical Sciclone Pharmaceuticals Inc
Publication of MY115157A publication Critical patent/MY115157A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2292—Thymosin; Related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MYPI94002830A 1993-10-26 1994-10-25 Method and composition for treatment of autoimmune hepatitis MY115157A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/141,013 US5468729A (en) 1993-10-26 1993-10-26 Method for treatment of autoimmune hepatitis

Publications (1)

Publication Number Publication Date
MY115157A true MY115157A (en) 2003-04-30

Family

ID=22493765

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI94002830A MY115157A (en) 1993-10-26 1994-10-25 Method and composition for treatment of autoimmune hepatitis

Country Status (8)

Country Link
US (1) US5468729A (OSRAM)
AU (1) AU8086894A (OSRAM)
MY (1) MY115157A (OSRAM)
PH (1) PH31319A (OSRAM)
SG (1) SG46620A1 (OSRAM)
TW (1) TW249754B (OSRAM)
WO (1) WO1995011696A1 (OSRAM)
ZA (1) ZA948252B (OSRAM)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9806632D0 (en) * 1998-03-28 1998-05-27 Stevenson Robert Peptide factor
NZ532310A (en) * 2001-10-05 2007-02-23 Combinatorx Inc Combinations comprising a tetra-substituted pyrimidopyrimidine and a corticosteroid for the treatment of immunoinflammatory disorders
UA80957C2 (en) * 2001-11-01 2007-11-26 Sciclone Pharmaceuticals Inc Method of administering a thymosin alpha 1 peptide
TW200517114A (en) * 2003-10-15 2005-06-01 Combinatorx Inc Methods and reagents for the treatment of immunoinflammatory disorders
WO2007139753A2 (en) * 2006-05-22 2007-12-06 Combinatorx, Incorporated Methods and compositions for the treatment of diseases or conditions associated with increased c-reactive protein, interleukin-6, or interferon-gamma levels
MX2009002893A (es) 2006-09-18 2009-07-10 Raptor Pharmaceutical Inc Tratamiento de trastornos hepaticos mediante la administracion de conjugados de la proteina asociada al receptor (rap).
ITRM20060584A1 (it) * 2006-10-27 2008-04-28 Francesco Bistoni Uso della timosina alfa 1 la preparazione di un medicamento per la prevenzione e la cura delle malattie autoimmuni
EP2427213B1 (en) * 2009-05-08 2015-04-01 Sciclone Pharmaceuticals, Inc. Alpha thymosin peptides as vaccine enhancers
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
KR102536881B1 (ko) 2011-04-29 2023-05-26 셀렉타 바이오사이언시즈, 인크. 항원-특이적 이펙터 ｔ 세포의 결실을 위한 관용원성 합성 나노운반체
MX380164B (es) 2013-05-03 2025-03-12 Selecta Biosciences Inc Uso de una macromolécula terapéutica y una composición que comprende nanoportadores sintéticos que se unen a inmunosupresores para reducir la hipersensibilidad tipo i y tipo iv en un sujeto.
CN106715699A (zh) 2014-09-07 2017-05-24 西莱克塔生物科技公司 用于减弱抗病毒转移载体免疫应答的方法和组合物
ES3036482T3 (en) 2017-03-11 2025-09-19 Cartesian Therapeutics Inc Methods and compositions related to combined treatment with anti-inflammatories and synthetic nanocarriers comprising an immunosuppressant

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4444757A (en) * 1981-11-16 1984-04-24 Research Corporation Use of thymosin as an anti-diabetes and anti-hypertensive disease agent
TW224053B (OSRAM) * 1991-09-13 1994-05-21 Paul B Chretien

Also Published As

Publication number Publication date
AU8086894A (en) 1995-05-22
PH31319A (en) 1998-07-06
TW249754B (OSRAM) 1995-06-21
MX9408106A (es) 1997-09-30
ZA948252B (en) 1996-04-22
SG46620A1 (en) 1998-02-20
US5468729A (en) 1995-11-21
WO1995011696A1 (en) 1995-05-04

Similar Documents

Publication Publication Date Title
PL299163A1 (en) Method of conducting lepaeoscopic operations in particular those of hernia and leparoscopic apparatus therefor
MY115157A (en) Method and composition for treatment of autoimmune hepatitis
DE3573876D1 (en) X-ray source and x-ray lithography method
OA09633A (en) Tissue graft composition and method
EP0454122A3 (en) Method and apparatus for treating medical wastes
HU9502587D0 (en) Use of, and method of treatment using, carbazolyl-(4)-oxypropanolamine compounds for inhibition of smooth muscle cell proliferation
PL320484A1 (en) Method of treating diabetes using kgf
AU8798091A (en) Method for treating gas and apparatus used therefor
EP0327093A3 (en) Electron beam exposure method and apparatus
GB9014307D0 (en) Method of treatment and compositions therefor
AU1193995A (en) An apparatus and method of waste treatment
EP0627930A4 (en) COMPOSITION AND METHOD FOR TREATING HEPATITIS B.
AU1329895A (en) Metallic implant and process for treating a metallic implant
AU9087591A (en) Composition and method for treating metal
EP0253702A3 (en) Method and apparatus for the treatment of waste in an apparatus for accelerated fermentation
AU7210491A (en) Method and device for continuously treating of fuel
UA43337C2 (uk) Гормональний засіб для лікування вугрів
ZA952797B (en) Method of treating auto-immune diseases using type one interferons
IL90187A0 (en) Method for treating an auto-immune disease using succinyl-acetone and pharmaceutical compositions containing the same
JPS6431983A (en) Metal treatment composition and method
EP0746315A4 (en) USE OF CARBAZOLYL- (4) -OXYPROPANOLAMINE COMPOUNDS FOR INHIBITING CELL PROLIFERATION OF SMOOTH MUSCLES AND METHOD OF TREATMENT THEREOF
CS61691A2 (en) Composition for dung-water treatment and method of dung-water treatment
GB2299271B (en) An apparatus and method of waste treatment
GB9223836D0 (en) Method of controlling an electron beam in an electron accelerator and an electron accelerator
ZA895954B (en) Process and apparatus for the manufacture of ferrochromium